Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Each time we hear this it’s the long-term NWBO shareholders like myself who get the pain while any shorts that might be out there laugh all the way to the bank.
If empty boasting was to be believed the shorts have been frightened and desperate for a decade now. Yet here they are when they’ve had years to exit despite being desperate? Something doesn’t add up and I suspect the folks who say they’re frightened and desperate might have been wrong.
Maybe this time will be different.
We’ll see but it is important to remember that NWBO cannot just release news and expect it to raise the SP. they gave to have strong follow through including on the media side.
Cassie it could be they’re just messing with you to give you false hope.
How many times have you heard ‘the shorts are scared’ and ‘they’re really desperate with their attacks’ or ‘their arguments are really weak now’ with the implication that news must therefore be coming and then, time and time again, there’s no news?
I hope things really happen this November and 1 years after the JAMA article and 3 years after data lock we finally get submission to a regulator and the click finally started on an up or down vote on approval.
If that happens though, it has zero to do with chatter in the peanut gallery.
Can you show us some of your old posts where you clearly articulated the position?
After Friday the 13th all of us would do well to save the boasting and taunts until after NWBO management delivers.
Learning Curve was right and I was wrong and I believe you were wrong with me on trusting NWBO’s August 28, 2023 PR.
It is interesting because those two have been resolutely against the science of NWBO for a very long time now. There was no ambiguity in their position.
NWBO is not a scam, it’s a buy.
NWBO is a legitimate company with two closely related and effective technologies (3 if you count the DCVax Prostate) but management and governance limitations.
Despite the way it is run, NWBO has a lot more upside potential than downside potential though it does have sideways potential if NWBO misses their new November expectation for submission. If they hit it then we go and probably stay above $1 as FOMO builds as MHRA approval or at least a binary event looms and folks place flyers on the stock. Even if we have a ‘buy the rumor, sell the news’ situation NWBO will definitely not go back as low as today’s price should MHRA approve so it’s a buy at this level.
With NWBO delays are just that: delays.
The delays do not mean that we get a better result like a simultaneous submission. Instead we wait longer for what was anticipated.
Further, delays now do not mean we have to wait less time on subsequent steps, as the history here demonstrated.
Those saying things will happen better or faster than expected have been just as wrong as saying milestones would never happen, and arguably more damaging to market sentiment (to the limited extent the peanut gallery had any impact) as the naysayers.
Extra time spent is simply wasted and we get nothing for it except what we expected - we just get it later than expected.
JD is not so much right or wrong as just trolling shareholders by switching to long or short and then back again based upon no clear reason. They seldom if ever provide a basis for their ‘predictions’ so there’s nothing to debate.
For longs JD’s positive predictions in a news vacuum cause a brief flare of hope goes up hoping he sees or knows something only to be cruelly be snuffed out when nothing happens or bad things happen.
JD’s negative predictions just sting longs but they give longs nothing to debate are so doubly annoying.
JD’s flip flopping means they have less credibility with all sides than even the folks hated by each shareholder faction so it’s hard to believe JD is a trader who thinks they can influence the price. They’re just a very subtle troll.
Even taking your word at face value about Bigger, no I don’t think he is exiting this investment just yet.
That said Bigger benefits from having credibility a lot more than an average investor like ourselves.
He can’t keep promoting something only for it to fall flat on its face as it did on Friday the 13th. The consequences of looking foolish for Bigger are measured in dollars, in our case we just have to avoid discussing NWBO this Thanksgiving unless NWBO follows through and we can add it to the list of things to be thankful for.
So while Bigger knows Friday the 13th was a horror show, Bigger hasn’t jumped in the running car and yet he’s not hiding behind the chain saws like the rest of us.
Bigger’s probably trying to get granularity on what the hell went wrong and see what is being done to fix it. He needs to know NWBO will not just strong him along as has happened to all prior investors and he presumably has the ability to find things out we can’t. If he’s satisfied with that answer, he’ll stay and if not he’ll discreetly leave. I doubt he’ll throw a stink bomb going out the door as he’ll look foolish and he saw Woodford’s fate.
These are just my opinions based upon what can be seen. Hopefully Bigger will communicate in the near future but he does not make it break this investment.
Only timely submission matters and after that approval. All else that we can foresee like partnerships or buyouts etc. flow from that.
I got the latest COVID-19 booster this month. Vaccines are great and like DCVax-L are not going to be 100% effective at prevention but are a lot better than the alternative. I never had to live in the shadow of polio or smallpox and it wasn’t because those diseases magically disappeared.
When new investors come in here and see supporters of DCVax-L are spouting conspiracy theories it makes this treatment look like snake oil and the company like a cult. They might or might not cut through the noise and stay long enough to see that this is a great product. Whatever else we think about each other’s views I think we can agree on that.
If NWBO actually monetized approvals from the other regulators then that would help as money talks and everything else walks. The patients being treated in 1st world countries but not here would also pressure the FDA to avoid least not slow walk things.
It was repeatedly indicated that NWBO’s ‘anticipation’ could be trusted because unlike other milestones, this one was 100% in NWBO’s control.
That point was made many times before October 13, 2023 and yet no one rebutted it by saying “You know NWBO must use a publisher and so as with the article review process, outsiders can create delays and so NWBO has a lot less than 100% control of when they submit.”
Given the failure to rebut, it is clear that few shareholders knew a publisher was a necessity until after NWBO management fell short and issued their last PR making excuses.
It’s amazing how many extra steps and extra aspects are only ‘obvious’ after another foul up but are so little discusses beforehand.
You have an interesting perspective but a vague response after such a screw up does not restore trust. They had their chance.
As for the court case, I rather think this delay and failure to follow through is either neutral or benefits the defendants. It doesn’t make NWBO look good and even if the foul up cannot be used legally it can belie NWBO’s narrative and strengthen the defendant’s narrative the court of public opinion. Thus the theory that NWBO imposed a delay due to line up with the court case makes little sense as a result but then again, and to our cost, NWBO often does things that seem to make little sense.
All of the stuff Bio99 celebrates about on government initiatives that might somehow be related to NWBO are besides the point.
We’re investors and our product is (supposed) to be at the goal line. Maybe this stuff will help Direct but that won’t matter before NWBO goes big or goes home.
There was talk about the Cancer Moonshot until we found out how woefully ignorant they at least allowed themselves to appear on immunotherapy and especially DCVax-L.
Investors here know what Right to Try, EAMS and HE did for our SP.
Outside of emergency an takes forever and has a habit of not giving out enough money and making what it does give out hard to access and distributes it more due to political imperatives than anything else.
A fair point, but still more something nice than a driver of the SP.
I assume you’re implying that if the Regent’s approves Dr. Liau getting outside employment with NWBO (paid or not) then that means they endorse NWBO.
Dr. Liau might have to get outside employment approval from her employer like many public employees do since an approval process helps avoid conflicts of interest.
In general bosses do not want to get sued for discrimination for approving outside employment for some employees while not approving it for others so they are going to restrict their focus to obvious ethical issues and are really vetting NWBO and saying it’s a good or bad firm as they are making sure that whatever she is doing would not create conflicts of interest with her UCLA role.
Maybe UCLA has stricter standards than that.
I have no idea what happened to Dr. Buzdar.
There never was any FUD but only truth.
That said, the old days are the new days.
I notice that after another lost year we’ve gone through another cycle where we’re looking towards news in November/December and people are saying how great next year will be.
No one has adequately explained why anyone is impressed that Dr. Liau joining the SAB is a big deal.
She already has a huge stake in DCVax-L succeeding and Direct moving forward because they are her life’s work.
Now if a former critic like Dr. Buzdar joined and made a favorable statement while doing, that would be with noticing.
I’m sorry you sold today but you might have made the best decision for yourself. The best thing is go since you have no money tied up here anymore, as the rest of us do.
Submitting to the regulator should be 100% in NWBO’s control but then after they miss we find out they have outsourced even the most basic functions.
NWBO will never answer the question of what did they know and when did they know it.
I think they realized they had to tell us something as the negative reaction from shareholders calling in became clear so the PR itself was probably written late.
Even then NWBO studiously avoided explaining exactly what went wrong, probably in the hopes investors would whistle past the graveyard and convince themselves the delay was a good thing being made into a bad thing.
NWBO has trained so many seals to hold balls on their noses that they don’t even have to say such things anymore. They can rely on shareholders to go get the ball themselves sbd not even demand a fish for it. With the big talk about Orbis (that is unfortunately likely to come to nothing as all supposed great things behind the scenes used to justify additional waits), NWBO calculated correctly.
I thought you would consider Hoff a good actor and not a fabricator.
FeMike I checked the list of banned individuals for this board and neither poster is on it.
While I have little use for either person, the real reason that some don’t show their faces here and some took a few days to return is that Friday the 13th was a huge embarrassment.
To be fair I am as foolish as Hoff and K as I was proven wrong to trust in NWBO management to actually care about repairing their credibility with the market and shareholders and am embarrassed to have been fooled by them (for the last time but still too many times) I at least have them the October 31, 2023 deadline because I thought it was too good to be true for them yo he perfectly on time. I had no idea they would blow the time frame altogether and put us at a foreseeable risk of not having submission in 2023 at all.
Trading NWBO is legally legitimate, just like all the things NWBO management has said and done are legitimate in a legal sense.
That does not make either approach right and the two problems reinforce one another.
Trading is not the primary problem but it sure helps amplify the problems created by management issues.
One would reasonably think that NWBO management’s recent actions would not help their case arguing that the SP is low due to manipulation rather than factors like poor communication and limited execution over a long period of time that created lack of confidence in the market.
Thus I doubt NWBO has gotten too cute and is delaying submission to coincide with some event in their court case.